143 related articles for article (PubMed ID: 37861550)
21. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma.
Gao X; Wang X; Zhang S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341252
[TBL] [Abstract][Full Text] [Related]
22. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
23. Association of abnormal NDUFB2 and UQCRH expression with venous thromboembolism in patients with liver cirrhosis.
Tan Y; Ma Y; Guo S; Lin Y
Medicine (Baltimore); 2024 Jan; 103(1):e36868. PubMed ID: 38181234
[TBL] [Abstract][Full Text] [Related]
24. Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study.
Jia W; Wu Q; Li R; Hou S; Kang C
Medicine (Baltimore); 2024 May; 103(18):e37984. PubMed ID: 38701255
[TBL] [Abstract][Full Text] [Related]
25. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
26. The role of CD14 and CSF1R in osteoarthritis and gastritis.
Zheng M; Li Z; Feng Y; Hou S; Zhang J; Kang C
Medicine (Baltimore); 2023 Oct; 102(43):e35567. PubMed ID: 37904379
[TBL] [Abstract][Full Text] [Related]
27. CD3D and CD247 are the molecular targets of septic shock.
Yang Q; Feng Z; Ding D; Kang C
Medicine (Baltimore); 2023 Jul; 102(29):e34295. PubMed ID: 37478215
[TBL] [Abstract][Full Text] [Related]
28. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis.
Ye Q; Lei L; Aili AX
Eur J Gynaecol Oncol; 2015; 36(3):283-9. PubMed ID: 26189254
[TBL] [Abstract][Full Text] [Related]
30. Roles of DSCC1 and GINS1 in gastric cancer.
Hou S; Zhang J; Chi X; Li X; Zhang Q; Kang C; Shan H
Medicine (Baltimore); 2023 Oct; 102(43):e35681. PubMed ID: 37904396
[TBL] [Abstract][Full Text] [Related]
31. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
[TBL] [Abstract][Full Text] [Related]
32. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
33. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma.
Zhang J; Gao Q; Hou S; Chi X; Zheng M; Zhang Q; Shan H; Zhang X; Kang C
Medicine (Baltimore); 2024 Feb; 103(5):e37056. PubMed ID: 38306561
[TBL] [Abstract][Full Text] [Related]
34. Identifying a Three-Gene Signature and Associated Drugs for Hepatitis B Virus-Related Hepatocellular Carcinoma Using Comprehensive Bioinformatics Analysis.
Tan Y; Zhang M; Chen X; Deng Y
Tohoku J Exp Med; 2022 Sep; 258(2):149-157. PubMed ID: 36002253
[TBL] [Abstract][Full Text] [Related]
35. MYLK and CALD1 as molecular targets in bladder cancer.
Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
[TBL] [Abstract][Full Text] [Related]
36. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
37. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
[TBL] [Abstract][Full Text] [Related]
38. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis.
Li Y; Li J; He T; Song Y; Wu J; Wang B
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553600
[TBL] [Abstract][Full Text] [Related]
39. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
[TBL] [Abstract][Full Text] [Related]
40. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
